Endothelin 1 protects HN33 cells from serum deprivation-induced neuronal apoptosis through Ca2+-PKC alpha-ERK pathway
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Moon Ho | - |
dc.contributor.author | Lee, Dae Hie | - |
dc.date.accessioned | 2021-09-09T10:59:25Z | - |
dc.date.available | 2021-09-09T10:59:25Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2008-02-29 | - |
dc.identifier.issn | 1226-3613 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/124051 | - |
dc.description.abstract | Endothelins (ETs), which were originally found to be potent vasoactive transmitters, were known to be implicated in nervous system, but the mode of mechanism remains unclear. ETs (ET-1, ET-2, and ET-3) were added to HN33 (mouse hippocampal neuron X neuroblastoma) cells. Among the three types of ET, only ET-1 increased the intracellular calcium levels in a PLC. dependent manner with the induction of ERK 1/2 activation. As the result of ET-1 exposure, the survival rate of HN33 cells and the PKC alpha. translocation into the plasma membrane were increased. We suggest that ET-1 participated in the neuroprotective effect involving the calcium-PKC alpha-ERK1/2 pathway. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | RAT-BRAIN | - |
dc.subject | SUBSTRATE MARCKS | - |
dc.subject | NERVOUS-SYSTEM | - |
dc.subject | KINASE-C | - |
dc.subject | RECEPTOR | - |
dc.subject | HIPPOCAMPUS | - |
dc.subject | EXPRESSION | - |
dc.subject | SURVIVAL | - |
dc.subject | PEPTIDE | - |
dc.subject | CLONING | - |
dc.title | Endothelin 1 protects HN33 cells from serum deprivation-induced neuronal apoptosis through Ca2+-PKC alpha-ERK pathway | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Moon Ho | - |
dc.contributor.affiliatedAuthor | Lee, Dae Hie | - |
dc.identifier.doi | 10.3858/emm.2008.40.1.92 | - |
dc.identifier.scopusid | 2-s2.0-40449120485 | - |
dc.identifier.wosid | 000253876400011 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL AND MOLECULAR MEDICINE, v.40, no.1, pp.92 - 97 | - |
dc.relation.isPartOf | EXPERIMENTAL AND MOLECULAR MEDICINE | - |
dc.citation.title | EXPERIMENTAL AND MOLECULAR MEDICINE | - |
dc.citation.volume | 40 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 92 | - |
dc.citation.endPage | 97 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001246452 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | RAT-BRAIN | - |
dc.subject.keywordPlus | SUBSTRATE MARCKS | - |
dc.subject.keywordPlus | NERVOUS-SYSTEM | - |
dc.subject.keywordPlus | KINASE-C | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | HIPPOCAMPUS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | PEPTIDE | - |
dc.subject.keywordPlus | CLONING | - |
dc.subject.keywordAuthor | calcium | - |
dc.subject.keywordAuthor | cell survival | - |
dc.subject.keywordAuthor | endothelins | - |
dc.subject.keywordAuthor | mitogen-activated protein kinase 1 | - |
dc.subject.keywordAuthor | neurons | - |
dc.subject.keywordAuthor | protein kinase C | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.